456
Views
24
CrossRef citations to date
0
Altmetric
Original Articles

Dust diseases and the legacy of corporate manipulation of science and law

, &

References

  • Merewether ERA. A memorandum on asbestosis. Tubercle. 1933;15:109–18.
  • Hobart, G, Letter to V. Brown. Hobart and Minard, Newark New Jersey, Dec. 15. 1934.
  • Smith W. Proof of death statement of the employer and attending physician, metropolitan life insurance company. Charleston, SC: Standard Certificate of Death, State of South Carolina, Bureau of Vital Statistics, State Board of Health; 1934.
  • Gardner L. Outline of proposed monograph on asbestos, Saranac Laboratory Study under Grant from Asbestos Association. 1943.
  • Cook WA. Introduction to ‘symposium on threshold limits.’ Am Ind Hyg Assoc. 1956;7(3):273–274.
  • Garrard HG. State of the art as a defense – is it real? Chicago: Defense Research Institute; 1987.
  • Walmer CR. Foundation facts. Trans Bulletin, 22nd Annual Meeting of the Industrial Hygiene Foundation, Pittsburgh, Pa: October 30–31, 1957.
  • Industrial Hygiene Foundation of America. Members of the Industrial Hygiene Foundation; 1959. Annual Report.
  • Industrial Hygiene Foundation of America; 1968. Annual Report.
  • Unknown. Environmental cancer. JAMA. 1944;126:836.
  • Noro L. Occupational diseases. Helsinki: Otava; 1945.
  • Macklin MT, Macklin CC. Does chronic irritation cause primary carcinoma of the human lung? Arch Path. 1940;30:924–55.
  • Wolff A. Asbestosis pulmonum. Nordisk Hyg Tidskr. 1940;21:1–40.
  • Lecoeur J. L’Etude des cancers professionelles. Presse Med. 1942;50:415–8.
  • Levin ML. Epidemiology of cancer. Am J Public Health. 1944;34:611–20.
  • Tabershaw IR, Bowditch M. Industrial hygiene in 1944. New Engl J Med. 1944;231:706–10.
  • Heuper WC. Industrial management and occupational cancer. Occup. Med. 1946;2:190–200.
  • Luton P, Champeix J. Study of asbestosis. Arch Mal. Profess. 1946;7:365–78.
  • Egilman D, Reinert A. The origin and development of the asbestos threshold limit value: scientific indifference and corporate influence. Int J Health Serv. 1995;25(4):667–96.
  • Clark WI, Drinker P. Industrial medicine. New York: National Medical Book Company, Inc.; 1935.
  • Sayers, Ian; “Asbestos as a Health Hazard in the United Kingdom.” Union Carbide UK Internal Report, 1967.
  • Dodson RF, Hammar SP, editors. Asbestos: risk assessment, epidemiology and health effects, 2nd edn. Boca Raton, FL: CRC Press, Taylor & Francis Group; 2011.
  • Responses of Defendant Manville Corporation Asbestos Disease Compensation Fund to Plaintiffs’ Interrogatories. Virginia: In the Circuit Court for the City of Newport News. D. Garland Moore and William L. Kelley, Plaintiffs, v. H. K. Porter Company, Inc., et al. Defendants. 1994.
  • Balzer L, Tebbens B., and C.C. Report to Health and Safety Committee National Insulation Manufacturers Association. 1971.
  • Braun DC. Letter to Hugh Jackson, Industrial Health Program, Johns-Manville; 1957.
  • Johnstone RT, Miller SE. Occupational diseases and industrial medicine. Philadelphia: W.B. Saunders Company; 1960.
  • Egilman D, Reinert A. Letter to the editor. Arch Environ Health. 2000;55(1):75–6.
  • Stokinger HE. Letter to D. C. Braun. Cincinnati: Archives of Industrial Hygiene and Occupational Medicine; 1958.
  • Castleman BI. Asbestos: medical and legal aspects, 5th edn. Austin, Boston, Chicago, New York: Aspen Publishers; 2005.
  • Braun DC. An Epidemiological Study of Lung Cancer in Asbestos Miners for Quebec Asbestos Mining Association, Quebec, Canada, July, 1956 to July, 1957, Industrial Hygiene Foundation of America, 1957.
  • Braun DC, Truan TD. An epidemiological study of lung cancer in asbestos miners. AMA Arc Ind Health. 1958;17(6):634–53.
  • Brown V. Letter to Kelly, Executive Vice-President of American Brake Block Division of American Brake Shoe Company, New York, NY; 1943.
  • Smith K. Letter to I. Sabourin. Johns-Manville: New York; 1957.
  • Johnstone RT. Silicosis and cancer. J Am Med Assoc. 1961;176:1.
  • Trimble G. Letter to the Editor. J Am Med Assoc. 1961;178(3):352–353.
  • Johnstone R. Letter to the editor from jama consultant. JAMA. 1961;178(1):353.
  • D. Egilman TB, Lee C. MetLife and its corporate allies: dust diseases and the manipulation of science, IJOEH. 2013;19(4):287–303.
  • Stokinger HE. Standards for safeguarding the health of the industrial worker. Public Health Rep. 1955;70:1–11.
  • Greenberg M. Biological effects of asbestos: New York Academy of Sciences 1964. Am J Ind Med. 2003;43(5):543–52.
  • Occupational Safety & Health Administration (OSHA). Occupational exposure to asbestos. Regulatory History. United States Department of Labor. [Cited 2013 October 30]; Available from: https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table = PREAMBLES&p_id = 775
  • Degussa. Letter to German customers. Translated by J. Goddard, 1972 June 14; 1971.
  • Public Hearing In the Matter of: Standard for Exposure to Asbestos Dust, Proposed Rule Making, before A. M. Goldberg, Hearing Examiner. Washington, D.C. US Department of Labor 1972 March 16).
  • Swetonic M. 1972 June 12, Memo. Asbestos Information Association.
  • Swetonic M. Speech to Asbestos Textile Institute. 1973 June 7.
  • Rhodes H. B. Memo to W. C. Thurber. 1975 May 30.
  • Hitchins RA. Report and recommendation of the temporary organization committee which was elected at the Symposium on Dust Problems; 1935 January 15; Pittsburgh, PA.
  • Dickson GL. Internal memo to J. T. Kelly. Union Carbide Corporation. 1983 October 20.
  • Union Carbide Corporation’s Responses to Plaintiffs’ First Set of Interrogatories and Requests for Production. Charles R. Latham et al. Plaintiffs, v. Garlock, Inc., et al. Defendants. In the District Court of Brazoria County, Texas, 23rd Judicial District; 2001.
  • Occupational Safety & Health Administration (OSHA). Occupational exposure to asbestos, tremolite, anthophyllite, and actinolite; Final Rules. Federal Register, June 20 1986;51(119). United States Department of Labor.
  • Johns Manville. Company History; 2013 [Cited 2013 December 30]. Available from: http://www.jm.com/corporate/56.htm
  • Brown V. Letter to M. F. Judd. Re: Mellon Institute of Industrial Research Symposium on Dust Problems. 1935 January 22.
  • Asbestos Information Association (AIA) Board of Directors Meeting minutes, Mayflower Hotel, Washington DC; 1976.
  • Affidavit of Philip E. Enterline, 1991 March 31. State of Florida; 1991.
  • Enterline P. Asbestos and cancer: the first thirty years (Unpublished Draft); 1978.
  • Enterline PE. Asbestos and cancer: the international lag. Am Rev Respir Dis. 1978;118(6):975–8.
  • Enterline P. Changing attitudes and opinions regarding asbestos and cancer 1934–1965. Am J Ind Med. 1991;20:685–700.
  • McDonald JC, McDonald AD. Chrysotile, tremolite, and mesothelioma. Science. 1995;267(5199):776–7.
  • Proctor DM, Panko JP, Liebig EW, Paustenbach DJ. Estimating historical occupational exposure to airborne hexavalent chromium in a chromate production plant: 1940–1972. J Occup Environ Hyg. 2004;1(11):752–67.
  • Paustenbach DJ, Finley BL, Lu ET, Brorby GP, Sheehan PJ. Environmental and occupational health hazards associated with the presence of asbestos in brake linings and pads (1900 to present): a ‘state-of-the-art’ review. J Toxicol Environ Health B Crit Rev. 2004;7(1):25–80.
  • Hoffman S, Radcliff T. Personal Communication with D. Egilman, 2011 June 30.
  • Rosner D, Markowitz G. A ‘gift of God’? The public health controversy over leaded gasoline during the 1920s. Am J Public Health. 1985;75(4):344–52.
  • Rosner D, Markowitz G. Deadly dust: silicosis and the politics of occupational disease in twentieth-century America. Princeton, NJ: Princeton University Press; 1991.
  • Markowitz GE, Rosner D. Deceit and denial: the deadly politics of industrial pollution. Berkeley, CA: University of California Press; 2002.
  • Markowitz G, Rosner D. The limits of thresholds: silica and the politics of science, 1935 to 1990. Am J Public Health. 1995;85(2):253–62.
  • Pneumoconiosis Case Summaries from the Vorwald Archives, Armed Forces Institute of Pathology, Bethesda, MD. 1952.
  • Egilman DS, Bohme SR. A brief history of warnings. In: Wogalter MS, editor. Handbook of warnings. Mahwah, NJ: Lawrence Erlbaum Associates; 2006. p. 11–8.
  • Egilman DS, Ardolino EL, Howe S, Bird T. Deconstructing a state-of-the-art review of the asbestos break industry. New Solutions. 2011;21(4):545–71.
  • Egilman D, Bagley S, Connolly S. Anything but beryllium: the beryllium industry’s corruption of safety information. Am J Ind Med. 2002;42(3):270–1.
  • Egilman DaS. Egilman, D, Scout. Corporate corruption of science – the case of chromium(VI). Int J Occup Environ Health. 2006;12(2):169–76.
  • Egilman D. Manipulated data in Shell’s Benzene Historical Exposure Study. Int J Occup Environ Health. 2007;13(2):222–32.
  • Egilman D. The Beryllium ‘double standard’ standard. Int J Health Serv. 2003;33(4):769–812.
  • Bohme SR, Zorabedian J, Egilman DS. Maximizing profit and endangering health: corporate strategies to avoid litigation and regulation. Int J Occup Environ Health. 2005;11(4):338–48.
  • Krumholz HM, Ross JS, Presler AH, Egilman DS. What have we learnt from Vioxx. Br Med J. 2007;334(7585):120–3.
  • Ong E, Glantz S. Constructing ‘sound science’ and ‘good epidemiology’: tobacco, lawyers, and public relations firms. Am J Public Health. 2001;91:1749–57.
  • Michaels D. Doubt is their product: how industry’s assault on science threatens your health. Oxford University Press: New York; 2008.
  • Occupational Safety and Health Administration (OSHA). Asbestos (all forms). United States Department of Labor. [Cited 2013 June 6]; Available from: http://www.osha.gov/dts/chemicalsampling/data/CH_219600.html
  • Occupational Safety & Health Administration (OSHA). Occupational exposure to asbestos. Federal Register 1994 October 8;59. United States Department of Labor.
  • Castleman BI, Ziem G. Corporate influence on threshold limit values. Am J Ind Med. 1998;13:531–59.
  • Moodie R, Stuckler D, Montiero C, Sheron N, Neal B, Thamarangsi T, et al. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet. 2013;381:670–79.
  • Egilman D, Howe S. Against anti-health epidemiology: corporate obstruction of public health via manipulation of epidemiology. Int J Occup Environ Health. 2007;13(1):118–24.
  • Egilman D, Kim J, Biklen M. Proving causation: the use and abuse of medical and scientific evidence inside the courtroom – an epidemiologist’s critique of the judicial interpretation of the Daubert ruling. Food Drug Law. 2003;58(2):223–50.
  • Egilman D, Mailloux C, Valentin C. Popcorn-worker lung caused by corporate and regulatory negligence: an avoidable tragedy. Int J Occup Environ Health. 2007;13(1):85–98.
  • Egilman DS, Bohme SR. Chevron-Texaco’s science. Int J Occup Environ Health. 2005;11(4):456–7.
  • Egilman DS, Ehrle LH. Handling conflicts of interest between industry and academia. JAMA. 2003;289(24):3240; author reply 3240–1.
  • Egilman DS, Presler AH. Report of specific cardiovascular outcomes of the ADVANTAGE trial. Ann Intern Med. 2006;144(10):781.
  • Egilman DS, Walta M. Breast implant verdicts resulted from corporate misconduct and legitimate science. Am J Public Health. 1999;89(11):1763–4.
  • Paustenbach DJ, Richter RO, Finley BL, Sheehan PJ. An evaluation of the historical exposures of mechanics to asbestos in brake dust. Ann Occup Hyg. 2003;18(10):786–804.
  • Paustenbach DJ, Sage A, Bono M, Mowat F. Occupational exposure to airborne asbestos from coatings, mastics, and adhesives. J Expo Anal Environ Epidemiol. 2004;14(3):234–44.
  • Mowat F, Bono M, Lee RJ, Tamburello S, Paustenbach D. Occupational exposure to airborne asbestos from phenolic molding material (Bakelite) during sanding, drilling, and related activities. Ann Occup Hyg. 2005;2(10):497–507.
  • Mangold C, Clark K, Madl A, Paustenbach D. An exposure study of bystanders and workers during the installation and removal of asbestos gaskets and packing. Ann Occup Hyg. 2006;3(2):87–98.
  • Paustenbach DJ, Finley BL, Sheehan PJ, Brorby GP. Re: evaluation of the size and type of free particulates collected from unused asbestos-containing brake components as related to potential for respirability. Am J Ind Med. 2006;49(1):60–1; author reply 2–4.
  • Paustenbach DJ, Madl AK, Donovan E, Clark K, Fehling K, Lee TC. Chrysotile asbestos exposure associated with removal of automobile exhaust systems (ca. 1945–1975) by mechanics: results of a simulation study. J Exposure Sci Environ Epidemiol. 2006;16(2):156–71.
  • Williams PR, Phelka AD, Paustenbach DJ. A review of historical exposures to asbestos among skilled craftsmen (1940–2006). J Toxicol Environ Health B Crit Rev. 2007;10(5):319–77.
  • Madl AK, Clark K, Paustenbach DJ. Exposure to airborne asbestos during removal and installation of gaskets and packings: a review of published and unpublished studies. J Toxicol Environ Health B Crit Rev. 2007;10(4):259–86.
  • Williams P, Paustenbach D, Balzer JL, Mangold C. Retrospective exposure assessment of airborne asbestos related to skilled craftsmen at a petroleum refinery in Beaumont, Texas (1940–2006). J Toxicol Environ Health A. 2007;70(13):1076–107.
  • Finley BL, Richter RO, Mowat FS, Mlynarek S, Paustenbach DJ, Warmerdam JM, et al. Cumulative asbestos exposure for US automobile mechanics involved in brake repair (circa 1950s–2000). J Exposure Sci Environ Epidemiol. 2007;17(7):644–55.
  • Madl AK, Scott LL, Murbach DM, Fehling KA, Finley BL, Paustenbach DJ. Exposure to chrysotile asbestos associated with unpacking and repacking boxes of automobile brake pads and shoes. Ann Occup Hyg. 2008;52(6):463–79.
  • Murbach DM, Madl AK, Unice KM, Knutsen JS, Chapman PS, Brown JL, et al. Airborne concentrations of asbestos onboard maritime shipping vessels (1978–1992). Ann Occup Hyg. 2008;52(4):267–79.
  • Pierce JS, McKinley MA, Paustenbach DJ, Finley BL. An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma. Crit. Rev. Toxicol. 2008;38(3):191–214.
  • Madl AK, Gaffney SH, Balzer JL, Paustenbach DJ. Airborne asbestos concentrations associated with heavy equipment brake removal. Ann Occup Hyg. 2009;53(8):839–57.
  • Hollins DM, Paustenbach DJ, Clark K, Mangold CA. A visual historical review of exposure to asbestos at puget sound naval shipyard (1962–1972). J Toxicol Environ Health B Crit Rev. 2009;12(2):124–56.
  • Richter RO, Finley BL, Paustenbach DJ, Williams PR, Sheehan PJ. An evaluation of short-term exposures of brake mechanics to asbestos during automotive and truck brake cleaning and machining activities. J Exposure Anal Environ Epidemiol. 2009;19(5):458–74.
  • Franke K, Paustenbach D. Government and Navy knowledge regarding health hazards of asbestos: a state of the science evaluation (1900 to 1970). Inhal Toxicol. 2011;23:1–20.
  • Donovan EP, Donovan BL, Sahmel J, Scott PK, Paustenbach DJ. Evaluation of bystander exposures to asbestos in occupational settings: a review of the literature and application of a simple eddy diffusion model. Crit Rev Toxicol. 2011;41(1):52–74.
  • Finley BL, Pierce JS, Phelka AD, Adams RE, Paustenbach DJ, Thuett KA, et al. Evaluation of tremolite asbestos exposures associated with the use of commercial products. Crit Rev Toxicol. 2012;42(2):119–46.
  • Berman DW, Sheehan PJ, Bogen KT, Holm SE. More on the dynamics of dust generation: the effects of mixing and sanding chrysotile, calcium carbonate, and other components on the characteristics of joint-compound dusts. Ann Occup Hyg. 2012;56(7):852–67.
  • Bernstein DM, Decker U, Gaering S, Kunzendorf P, Chevalier J, Holm SE. A Biopersistence study following exposure to chrysotile asbestos alone or in combination with fine particles. Inhal Toxicol. 2008;20:1009–28.
  • Bernstein DM, Rogers RA, Sepulveda R, Donaldson K, Schuler D, Gaering S, et al. The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short-term inhalation exposure: interim results. Inhal Toxicol. 2010;22(11):937–62.
  • Bernstein DM, Rogers RA, Sepulveda R, Donaldson K, Schuler D, Gaering S, et al. Quantification of the pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite-asbestos following short-term inhalation exposure. Inhal Toxicol. 2011;23(7):372–91.
  • Brorby GP, Sheehan PJ, Berman DW, Greene JF, Holm SE. Re-creation of historical hrysotile-containing joint compounds. Inhalation Toxicol. 2008;20:1043–53.
  • Brorby GP, Sheehan PJ, Berman DW, Bogen KT, Holm SE. Potential artifacts associated with historical preparation of joint compound samples and reported airborne asbestos concentrations. J Occup Environ Hyg. 2011;8:271–8.
  • Brorby GP, Sheehan PJ, Berman DW, Bogen KT, Holm SE. Exposures from chrysotile-containing joint compound: evaluation of new model relating respirable dust to fiber concentrations. Risk Anal. 2012.
  • Sheehan PJ, Berman DW, Bogen KT, Holm SE. Chamber for testing asbestos-containing products: validation and testing of a re-created chrysotile-containing joint compound. Ann Occup Hyg. 2011;55(7):797–809.
  • Jones SB. Development and evaluation of a semi-empirical two zone dust exposure model for a dusty construction trade. J Occup Environ Hyg. 2011;8:337–48.
  • Jones SB. Comparing two-zone models of dust exposure. J Occup Environ Hyg. 2011;8:513–9.
  • Simmons JB. Factors influencing dust exposure: finishing activities in drywall construction. J Occup Environ Hyg. 2011;8:324–36.
  • Matter of New York City Asbestos Litigations 2013 NY Slip Op 04127, Decided on 2013 June 6, Weitz & Luxenberg P. C., Plaintiffs, Respondents v. Georgia-Pacific LLC, Defendant-Appellant, (2013).
  • Sheehan JS. J. S. Sheehan (Antioch R & D) to G. B. Kirk (Oakland). Kaiser Gypsum Company, Inc. Inter-Office Memorandum, 1974 March 1.
  • Videotape Deposition of Bobby Joe Pigg. 2013 June 18. Ronald C. Nelson and Joanna Nelson vs. Allied Packing & Supply Inc, et al. In the Superior Court of the State of California in and for the County of Alameda.
  • Noorden RV. Toxicologist denies wrong-doing in asbestos case. Nature News Blog, 2013 Oct 8. [Cited 2013 Oct 30]; Available from: http://blogs.nature.com/news/2013/10/toxicologist-denies-wrong-doing-in-asbestos-case.html
  • Toxicology I. Corrigenda. Inhalation Toxicol. 2012;24:80.
  • Galvao A, Coelho E. Researchers absolve asbestos used in Brazil. O Estado de Sao Paulo. 1999.
  • Morris J. Exporting an epidemic: human toll reaches millions as asbestos industry expands worldwide. 2010 July 21,. [Cited 2013 October 12]; Available from: http://www.publicintegrity.org/2010/07/21/3401/exporting-epidemic
  • Bernstein D, Dunniga J, Hesterberg T, Brown R, Velasco JAL, Barrera R, et al. Health risk of chrysotile revisited. Crit Rev Toxicol. 2013;43(2):154–83.
  • Bang KM. Asbestosis and malignant mesothelioma mortality in the united states: an update. American Public Health Association Annual Meeting; 2011; Washington, DC.
  • LaDou J. The asbestos cancer epidemic. Environ Health Perspect. 2004;112(3):285–90.
  • Ramazzini C. Asbestos is still with us: repeat call for a universal ban. Int J Occup Environ Health. 2010;16:351–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.